Saloxicin By XYMOGEN Overview & Drug Interactions

Check For Interactions With Saloxicin

Supplement: Saloxicin by XYMOGEN

Saloxicin Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Saloxicin by XYMOGEN

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
2 Capsule(s)
Maximum serving Sizes:
2 Capsule(s)
Servings per container 60
UPC/BARCODE 871149000325

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Salicin
120 mg
Salicin --
Boswellia serrata extract
50 mg
Boswellia --
BerryVin High ORAC Berry Blend
40 mg
Proprietary Blend --
Strawberries
0 NP
Strawberry
Escobillo
0 NP
Acerola
Blueberries
0 NP
Blueberry
Cranberries
0 NP
cranberry
Grape extract
0 NP
Grape
Pomegranate Fruit Extract
0 NP
Pomegranate

Other Ingredients:
Hypromellose
Water
Tricalcium Phosphate
Microcrystalline Cellulose
Stearic Acid
Magnesium Stearate
Calcium Silicate
Silica


Label Statments:


Precautions
- Professional use only Not for resale on third-party websites, including, but not limited to, Amazon and eBay.
- Consult your healthcare professional prior to use.
- Individuals taking medication should discuss potential interactions with their healthcare professional.
- Do not use if tamper seal is damaged.
- Storage: keep tightly closed in a cool, dry place out of reach of children.
Suggested/Recommended/Usage/Directions
- Directions: take two capsules twice daily, or as directed by your healthcare professional.
Formula
- Saloxicin is formulated to support eicosanoid and cytokine balance and provide support for joint comfort. 5-LOXIN, a patented boswellia extract yielding concentrated 3-0-acetyl-11-keto-B-boswellic acid (AKBA), is found to exhibit the 5-lipoxygenase enzyme. Salicin from white willow bark is a natural inhibitor of both the COX-2 and 5-lipoxygenase enzymes. Bioflavonoid-rich BerryVin provides additional support for eicosanoid balance and antioxidant activity.
- Salix alba/Boswellia serrata
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Storage
- Storage: keep tightly closed in a cool, dry place out of reach of children.
Formulation
- Formulated to exclude: wheat, gluten, yeast, soy, animal and dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMO's), artificial colors, artificial sweeteners, and artificial preservatives.
- Vegetarian caps
FDA Statement of Identity
- Dietary Supplement
Seals/Symbols
- ePV (ePedigree Verification)
- Vegetarian caps Third-party GMP compliant verified
Brand IP Statement(s)
- Exclusive professional formulas
- S1. 5-LOXIN is a registered trademark of PL Thomas - Laila Nutra, LLC and is used under license. International patents pending. S2. BerryVin is a trademark of Cyvex Nutrition, Inc. Copyright 2021 XYMOGEN
General Statements
- Scan to learn more! This package is completely recyclable

Brand Information

See all products by this brand

Manufacturer
Name XYMOGEN Exclusive Professional Formulas
Street Address 6900 Kingspointe Pkwy.
City Orlando
State FL
ZipCode 32819
Phone Number 800-647-6100
Web Address www.xymogen.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.